Q64.12
Cloacal exstrophy of urinary bladder
Clinical Classification Guidelines
Medical Intelligence & Overview
Cloacal exstrophy of the urinary bladder is a rare congenital condition where the structures of the lower abdominal wall and urogenital organs are improperly formed at birth. This complex anomaly involves the exposure of the bladder and other reproductive and intestinal organs outside the body. It is classified under ICD-10 code Q64.12 and requires specialized medical care to address the multiple issues associated with this condition. Early diagnosis and intervention are crucial for managing health and improving outcomes.
Causes & Symptoms
Clinical Causes: Genetic factors: Certain genetic mutations or abnormalities during fetal development may contribute to the development of cloacal exstrophy. Environmental influences: Although less clearly understood, environmental factors during pregnancy might influence the development of congenital malformations. Incomplete embryonic development: The condition results from improper fusion and development of the lower abdominal structures during embryogenesis, specifically around the 4th to 6th week of gestation.
Key Symptoms: Exposed bladder: The outer surface of the bladder is visible outside the abdomen. Abnormalities of the reproductive organs: Presence of genital malformations such as duplicated or improperly formed reproductive structures. Intestinal abnormalities: Exposed or malformed intestines, often with defect in the abdominal wall. Prolapsed organs: Misplaced or protruding organs including parts of the intestine and urinary structures. Associated anomalies: Heart defects and other congenital abnormalities may be present alongside cloacal exstrophy. Irritation and infection: Exposure of internal organs increases risk of infection and skin irritation around the affected area.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of cloacal exstrophy typically occurs shortly after birth through physical examination, revealing the characteristic exposure of the bladder and associated anomalies. Imaging studies such as ultrasound, X-ray, or MRI can provide detailed views of the internal organs and assist in planning surgical intervention. Early consultation with a multidisciplinary team including pediatric surgeons, urologists, and geneticists is essential for comprehensive diagnosis and management.
Treatment Protocols: Managing cloacal exstrophy involves multiple stages of surgical and medical interventions. The primary goals are to close the defect, reconstruct affected organs, and restore functionality. Key treatment approaches include: - Immediate surgical procedures to cover or close the exposed organs, preventing infection and further damage. - Reconstruction of the urinary and reproductive systems to improve function and appearance. - Management of associated anomalies, which may require additional surgeries or medical support. - Long-term monitoring and supportive care, including developmental and psychological support. The complexity of this condition demands a coordinated care approach with a specialized team experienced in pediatric congenital anomalies. The prognosis depends on the severity of the anomalies and the success of surgical management, but advances in surgical techniques have improved outcomes significantly.
Clinical Advice & FAQs
Billing Guidance
Is Q64.12 a billable ICD-10 code?
Yes, Q64.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q64.12?
Clinical documentation must specify the nature of Cloacal exstrophy of urinary bladder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
